Pharmacovigilance Glossary

RWD (Real-World Data)

Imagine a diet plan that works perfectly in a controlled cooking class, then has to survive a chaotic family kitchen with takeout nights and picky eaters. Real-World Data captures how a medicine performs once it leaves the trial and enters everyday life.

What does it mean in plain English?

Real-World Data (RWD) is health information collected outside the tightly controlled environment of a clinical trial: electronic health records, insurance claims, pharmacy dispensing records, patient registries, even data from wearable devices. It captures how a medicine actually gets used by real patients, in all their messy variety.

This matters because clinical trials, however rigorous, only ever study a narrow slice of the population for a limited time. RWD fills in the rest of the picture: rare side effects that only show up after years of use, how the drug performs in elderly patients or those with multiple conditions, and whether it works as well outside the lab as it did inside it.

Two very different pictures

Same drug, same disease, but the data looks completely different depending on where it comes from. Hover each side.

Hover a panel to compare

In the Trial

Narrow, carefully screened patient group
Closely monitored, near-perfect adherence
Short follow-up window, then the study ends

In the Real World

Everyone: elderly patients, pregnancy, multiple conditions
Missed doses, other drugs, ordinary daily life
Years of use, long after the trial ended

Common Misconceptions

Myth

"If it's not from a proper clinical trial, isn't real-world data just messy, unreliable evidence?"

Truth

It's different, not worse. Real-world data trades the tight control of a trial for enormous scale and real-life relevance. Regulators increasingly treat well-analyzed RWD (once it's been properly studied, often called Real-World Evidence, or RWE) as a genuinely valuable complement to trial data, not a lesser substitute.